|
|
| Industrie Pharmaceutique > Etude de marché sectorielle |
| Roche case study: becoming a targeted medicine player |
|
|
|
|
€ 250,75 |
Editeur
: |
Datamonitor |
Langue
: |
Anglais |
Date de publication : |
Novembre 2005 |
Taille du document : |
15 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
Documents Publics |
1,200,000
documents |
Téléchargement illimités |
|
|
|
Etudes Privées |
50,000 rapports et études |
Paiement à la piéce |
|
|
|
|
| |
|
1.Télécharger nos rapports publics
Accés complet à plus de 1,2 Million de documents publics : études de marché, statistiques sectorielles, fiches pays, monographie d'entreprises, veille concurentielle, rapports annuels...
|
| Nos documents publics sur le même théme (2) |
|
|
|
| 54 pages | Janvier 2002 | Anglais
|
|
|
| Main
focus: |
aircraft,cns
|
| Research
focus: |
demand analysis,market size and estimates, |
| Geographic
focus: |
usa,mexico,united kingdom |
| |
|
|
|
|
| 51 pages | Février 2007 | Anglais
|
|
|
| Main
focus: |
cns,insomnia,alzheimer,anxiety,antidepressant,...
|
| Research
focus: |
market size and estimates,market outlook, |
| Geographic
focus: |
usa,france |
| |
|
|
|
|
| Autres recherches sur le même thème |
|
|
|
| |
| |
|
| |
|
2.
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Pain Therapeutics: A Strategic Re-evaluation.
198 pages | Août 2000 |
Pain management, though not a life-threatening disease, will have its proper place in the future healthcare system because the disability and economic loss in addition to personal suffering caused |
955,00 €
|
| |
| |
Obesity Drug Markets in the US and EU: Analysis of product pipelines and the competitive environment
148 pages | |
Obesity Drug Markets in the US and EUAnalysis of product pipelines and competitive environmentBusiness Intelligence for the Pharmaceutical IndustryBusiness Insights' portfolio of healthcare management |
3 068,00 €
|
| |
| |
Regulatory Affairs: Paths to Approval
113 pages | Février 1999 |
Area Specific Chapters : The regulatory systems governing clinical trials and drug approvals are examined for the US, Europe, and Australia, Canada and Japan, including analysis of the implicatio |
795,00 €
|
| |
| |
MarketWatch: Biotechnology
32 pages | |
Datamonitor's Biotechnology MarketWatch is a one-stop news shop for time-pressed executives.
It provides monthly insight into the key events in the Biotechnology industry.
The report contains th |
160,00 €
|
| |
| |
Commercial and Pipeline Insight: Fibromyalgia - Approvals legitimize condition and expose underserved patient population
193 pages | |
IntroductionWith a considerable patient potential and large medical unmet need, the untapped fibromyalgia market represents a lucrative opportunity for pharmaceutical companies.
Estimated to total |
12 160,00 €
|
| |
| |
Commercial and Pipeline Insight: Vaccines for Adults and the Elderly - New blockbuster opportunities ahead
161 pages | |
IntroductionVaccines have re-emerged as successful revenue generators for Big Pharma, with adults and the elderly now increasingly coming into focus as the next big opportunity in this sector.
An a |
12 320,00 €
|
| |
| |
Top Ten and Emerging Pharmaceutical markets
214 pages | Juillet 1999 |
Introduction : Provides the background to the report by identifying the major trends within global healthcare markets and how these interact and influence the markets for pharmaceuticals.
Mar |
795,00 €
|
| |
| |
The Pharmaceutical Outsourcing Outlook 1998-2003
199 pages | Juin 1999 |
The streamlining of pharmaceutical companies that has taken place in recent years has allowed them to focus resources and investment on core specialities.
This, in turn, has led to a greater re |
795,00 €
|
| |
| |
Healthcare In Scotland
52 pages | Mai 2000 |
The Scottish Presentation Includes:- The Structure Of The NHS In Scotland- The Funding Of The NHS In Scotland- Distribution Of The NHS Budget In Scotland- Segmentation Of Expenditure - Total Capital E |
327,00 €
|
| |
| |
Global Pharmaceutical: a market, company and disease analysis
150 pages | Octobre 1998 |
What will drive pharmaceutical market growth into the 21st Century? What are the key challenges facing pharmaceutical manufacturers? Who are the market leaders in each sector? What strategies ar |
795,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| Roche case study: becoming a targeted medicine player |
|
|
The case study focuses on Roche, which has undergone far-reaching changes on account of a new generation of drugs, repositioning itself away from a mainly CNS-focused pharmaceuticals giant, without totally giving up the CNS franchise, and in the process becoming an innovative, dedicated targeted medicine player.
|
|
The case study focuses on Roche, which has undergone far-reaching changes on account of a new generation of drugs, repositioning itself away from a mainly CNS-focused pharmaceuticals giant, without totally giving up the CNS franchise, and in the process becoming an innovative, dedicated targeted medicine player.
|
|
|
PPLSEN
|
|
|
|
|
